Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/15/24 19:44 | 5/13/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | 2 | M.d | 462 | 20.44 | 0 | 23 | 7 | 339 | D | |||||||||||||||
5/15/24 19:44 | 5/13/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | 2 | S.d | -462 | 20.44 | 0 | -23 | 339 | D | ||||||||||||||||
3/25/24 19:31 | 3/21/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Garber Alan M | CA | D | 2 | M.d | 921 | 21.57 | 0 | 43 | 36 | D | ||||||||||||||||
3/25/24 19:31 | 3/21/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Garber Alan M | CA | D | 2 | S.d | -921 | 21.57 | 0 | -43 | 36 | D | ||||||||||||||||
2/27/24 18:58 | 2/23/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Haley Patrick J. | CA | O | EVP,Comm | 1 | S | -1,009 | 21.45 | 0 | -47 | 419 | D | |||||||||||||||
2/22/24 17:08 | 2/21/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Johnson David Edward | NY | D | 1 | P | 3,933 | 20.70 | 0 | 190 | 20 | 1,119 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |